1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow FHD-286: new trials by email Literature Review of FHD-286 trials Research Report on FHD-286
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SMARCA4/2 Inhibitor for POU2F3-Positive SCLC FHD-286 - Small Cell Lung Cancer | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 20 | 2026-04-28 | 2026-10-26 |
Dana-Farber Cancer Institute (1)
United States (1)
Alissa Cooper (1)